The once-booming tech job market has contracted sharply, with software development postings down over 30% since February 2020, according to Indeed.com. Tech companies have shed around 137,000 jobs since January. This downturn, following years of aggressive hiring, marks a significant shift in the industry’s labor dynamics. Companies are pivoting from Read more…
Late last month, Brazilian Justice Alexandre de Moraes ordered X to suspend operations in Brazil after a months-long dispute with X owner Elon Musk. The conflict centered on Musk’s refusal to appoint a legal representative in the country and his refusal to take down disinformation and far-right accounts. However, on Read more…
The House Energy and Commerce Committee has approved the AM for Every Vehicle Act, which mandates that automakers include AM radio in new vehicles without additional charges. The bill passed the committee on a roll-call vote of 45-2 and now heads to the full House for final approval. The bill, Read more…
Instagram has introduced new safety features that make teenage accounts private by default, enhance parental supervision, and set messaging restrictions to protect young users, requiring parental approval for changes. Meta said users under 16 will now need a parent’s approval to change the restricted settings, dubbed “Teen Accounts,” which filter Read more…
Scientists in Brazil found microplastics in the brain tissue of cadavers, according to a new study published Monday in the journal JAMA Network Open. Mounting research over the last few years has found microplastics in nearly every organ in the body, as well as in the bloodstream and in plaque Read more…
Google said in a blog post today it will begin labeling AI-generated and AI-edited image search results later this year. The company will flag such content through the “About this image” window and it will be applied to Search, Google Lens, and Android’s Circle to Search features. Google is also Read more…
Neuralink said on Tuesday it has received the FDA’s “breakthrough device” designation for its experimental implant aimed at restoring vision. Called Blindsight, the device “will enable even those who have lost both eyes and their optic nerve to see,” said Neuralink founder Elon Musk. Reuters reports: The FDA’s breakthrough tag Read more…